Further mechanistic studies revealed a positive correlation between DERL3 expression and the expression of TGFB1 and stromal cell-related proteins, suggesting that high DERL3 expression enhances ccRCC progression by promoting EMT. This evidence concerns the gene DERL3 and nonpapillary renal cell carcinoma.